Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis

Pei-Ming Yang1, Wei-Chien Huang, Yi-Chu Lin

  • 1Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Insights

Blocking the IKK-NF-kappaB pathway inhibits lung cancer cell growth and metastasis. This approach enhances p53 stability, promoting cell cycle arrest and apoptosis in tumor cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Elevated nuclear factor-kappa B (NF-kappaB) signaling is implicated in various inflammatory diseases and cancers.
  • Targeting the inhibitor of kappa B kinase (IKK)-NF-kappaB pathway presents a potential therapeutic strategy.

Purpose of the Study:

  • To investigate the role of IKKbeta in lung adenocarcinoma progression.
  • To evaluate the therapeutic potential of inhibiting IKKbeta activity.

Main Methods:

  • Utilized a dominant-negative mutant of IKKbeta and IKKbeta inhibitors (CYL-19s, CYL-26z).
  • Assessed effects on A549 lung adenocarcinoma cells in vitro and in a mouse xenograft model.
  • Examined cell cycle progression, apoptosis, p53 stability, nuclear accumulation, promoter-binding activity, and p21 gene transcription.
  • Employed small interfering RNA (siRNA) for IKKbeta knockdown.

Main Results:

  • Loss of IKKbeta activity reduced proliferation, invasion, tumor formation, metastasis, and angiogenesis.
  • IKKbeta inhibition induced G1 and G2/M cell cycle arrest and apoptosis.
  • Inhibitors increased p53 protein stability, nuclear accumulation, and promoter-binding activity, enhancing p21 transcription.
  • IKKbeta knockdown potentiated these effects and correlated with p53 acetylation.

Conclusions:

  • IKKbeta inhibition is crucial for enhancing p53 stability and subsequent p21 expression.
  • This mechanism leads to cell cycle arrest and apoptosis in tumor cells, highlighting IKKbeta as a therapeutic target.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...